Kodiak Sciences Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 05:00PM GMT
Anupam Rama - JPMorgan Chase & Co, Research Division - VP and Analyst

All right. Let's go ahead and get started. Welcome, everyone, to the Wednesday morning of the 41st Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Priyanka Grover and Malcolm Kuno from the team. Our next presenting company is Kodiak and presenting on behalf of the company, we have CEO, Victor Perlroth. Victor?

Victor Perlroth - Kodiak Sciences Inc. - Co-Founder, Chairman, CEO & President

Thank you, Anupam. It's my pleasure to be here. Welcome to 2023. We have a large number of activities in progress and a lot of data that we're preparing, and we look forward to the progress of the year. Before we get started, let's remind that I may be making some forward-looking statements, so please refer carefully to risk factors in our SEC filings.

With all of the discussions going on in the field of biotech, maybe consternations. It's useful to remind ourselves where does Kodiak fit in. And I think we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot